Invus is a global investment firm headquartered in New York with a flexible, long-duration capital base. Unlike traditional VC funds, it is not constrained by short fund cycles and can support companies over very long time horizons. It invests across technology, life sciences, and consumer sectors, often with the capacity to write very large checks.

In healthcare and neuroscience, Invus has backed major companies including Neumora Therapeutics and other biotech platforms. Its strength lies in pairing deep financial flexibility with the willingness to stay involved over many years. For science-heavy businesses, that makes it especially attractive where development timelines are long and financing needs may evolve substantially over time.

Invus invests globally across the US, Europe, and Asia. For neurotech, it is most relevant to later or clinical-stage companies that need substantial capital, durable investor support, and strategic patience.